The FDA approves a new non-opioid pain pill, Journavx, to treat acute pain in adults. It's a first-generation non-addictive pain medicine.

Researchers have developed a new type of oral painkiller for chronic abdominal pain, inspired by the peptide hormone oxytocin ...

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...

A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in ... and are an important step towards developing novel, non-addictive treatments for ...

A trial of around 800 people with lower back pain suggested the cannabis-derived drug could be used as a painkiller ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Only around one in every 10 treatments were found to be effective in relieving lower back pain, according to a new study ...

CHATHAM, NEW JERSEY / ACCESS Newswire ... itself to become a leader in treating the chronic pain of fibromyalgia with a non-addictive treatment that's in the final stages of seeking FDA approval.

Opioid addiction remains a major public health crisis in the United States, with post-surgical prescriptions often playing a significant role.

CHATHAM, NJ / ACCESS Newswire / March 31, 2025 /This post was written and published as a collaboration between the in-house ...